Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
PhoreMost
Drugging the Undruggable®
TL;DR
Headquarters: Cambridge, UK
Employee count: 30
Core technology: SITESEEKER® phenotypic screening and PROTEINi® platforms
Focus: Discovering novel druggable sites and targeted protein degraders
Latest funding: Series B extension announced Sep 12, 2024; total funding reported ~$76.1M
Company Overview
Problem Domain
Drug discovery for challenging/undruggable targets; targeted protein degradation and small-molecule discovery.
Industry
Biotechnology / Drug discovery
Funding Track Record
Series B extension announced bringing Series B proceeds to over $50M; additional participation from existing investors including BGF, Dr Jonathan Milner, Amadeus Capital and Astellas Venture Management.
33,000,000 GBP
Oversubscribed Series B to support progression of PLK1 program; included investors XtalPi Inc., Astellas Venture Management, Trend Investment Group, and o2h ventures.
Investor Signal
“Parkwalk Advisors, BGF, Astellas Venture Management, Amadeus Capital, Dr Jonathan Milner, XtalPi”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
82,000+
Open Roles
4,700+
New This Week